MedPath

Non-surgical Treatment of Peri-implant Mucositis: FMUD vs FMUD and Air-Flow Master Piezon®

Not Applicable
Completed
Conditions
Peri-implant Mucositis
Registration Number
NCT05801315
Lead Sponsor
University of Siena
Brief Summary

The aim of the present study is to evaluate the adjunctive effect of glycine-powder air-polishing (GPAP) to full-mouth ultrasonic debridement (Fm-UD) in the treatment of peri-implant mucositis, and to determine the predictive role of implant and patient-level variables for disease resolution. Both treatments are described in the literature, but few studies are available on their comparison.

Detailed Description

52 patients (132 implants) with peri-implant mucositis were included in this randomized parallel arm clinical study. Following baseline variables assessment, participants received Fm-UD. Implants allocated to the test group (n=64) were additionally treated with GPAP. Clinical outcomes were evaluated at 3 and 12 months following intervention. Complete and partial disease resolution were defined as absence of BoP (DR1) or \<2 BoP+ sites (DR2), respectively.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
52
Inclusion Criteria
  • age between 18 and 70 years old;
  • presence of one implant loaded at least one year before;
  • bleeding on probing and/or suppuration of the peri-implant mucosa;
  • pain and/or tenderness of the peri-implant mucosa;
  • good general health conditions.
Exclusion Criteria
  • radiographic bone loss ≥ 2mm;
  • intake of anticoagulants, antiplatelet, antibiotic or cortisone drugs;
  • inability to perform oral hygiene maneuvers.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Bleeding on probing12 months

After probing dental and implant sites a dichotomic value (0/1) is assigned for each site. 0: not bleeding site; 1: bleeding site.

Secondary Outcome Measures
NameTimeMethod
Probing pocket depth change12 months

Change in probing pocket depth measured in millimeter through a periodontal probe.

Trial Locations

Locations (1)

AOUS

🇮🇹

Siena, Italy

AOUS
🇮🇹Siena, Italy

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.